Neurology Archives | Report Store

Disease Analysis: Alzheimer’s disease

Alzheimer’s disease is an irreversible, progressive, neurodegenerative disease that slowly affects memory, cognition, and function. It is a continuum of pathological changes in the brain that begin well before clinical symptoms emerge.

September 17, 2020

Find out more

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)

$1,318.00

This Market Spotlight report covers the Attention Deficit Hyperactivity Disorder (ADHD) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

September 10, 2020

Find out more

Market Spotlight: Insomnia

$1,318.00

This Market Spotlight report covers the insomnia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming events and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

September 3, 2020

Find out more

Market Spotlight: Migraine

$1,318.00

This Market Spotlight report covers the migraine market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

August 17, 2020

Find out more

Market Spotlight: Fragile X Syndrome

$1,318.00

This Market Spotlight report covers the Fragile X Syndrome market, comprising key pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of success, a discussion on disease epidemiology, and licensing and asset acquisition deals.

August 17, 2020

Find out more

Market Spotlight: Huntington’s Disease

$1,318.00

This Market Spotlight report covers the Huntington’s disease market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

August 14, 2020

Find out more

Market Spotlight: Systemic Hypertension

$1,318.00

This Market Spotlight report covers the Systemic Hypertension market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

August 14, 2020

Find out more

Market Spotlight: Myelofibrosis (MF)

$1,318.00

This Market Spotlight report covers the Myelofibrosis market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

August 14, 2020

Find out more

Market Spotlight: Cachexia

$1,318.00

This Market Spotlight report covers the Cachexia market, comprising epidemiology, key marketed and pipeline drugs, clinical trials, upcoming events, probability of success, patent information, and licensing and acquisition deals.

July 22, 2020

Find out more

Parkinson’s disease forecast and market analysis to 2035

Parkinson’s disease is a chronic and progressive neurodegenerative disorder characterized by tremors, rigidity, bradykinesia (slowness of movement), and postural instability.

July 17, 2020

Find out more

Disease Analysis: Epilepsy

Epilepsy is characterized by recurrent, unprovoked seizures. A seizure occurs when the normal pattern of neuronal activity is disturbed, defined by the National Institute of Neurological Disorders and Stroke as causing “strange sensations, emotions, and behavior or sometimes convulsions, muscle spasms, and loss of consciousness.”

May 22, 2020

Find out more

Disease Analysis: Multiple Sclerosis

Multiple sclerosis (MS) is an inflammatory, autoimmune disease characterized by neuronal demyelination leading to physical and cognitive disability.

May 12, 2020

Find out more

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

$1,318.00

This Market Spotlight report covers the Amyotrophic Lateral Sclerosis (ALS) market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, a 10-year disease incidence forecast, probability of success, and licensing and acquisition deals.

August 21, 2019

Find out more

Alzheimer’s Disease Market and Forecast Analysis 2034

Alzheimer’s disease is an irreversible, progressive, neurodegenerative, and fatal disease that slowly affects memory, cognition, and function.

February 25, 2019

Find out more

Pediatric Epilepsy KOL Interview – US, West

$599.00

A US expert in pediatric epilepsy provides insight into the approach to treating different forms of epilepsy. The key opinion leader (KOL) dives into the late-phase pipeline for epilepsy, as well as sharing insight into Epidiolex.

February 18, 2019

Find out more

Neurology

Disease Analysis: Alzheimer’s disease

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)​

Market Spotlight: Insomnia

Market Spotlight: Migraine

Market Spotlight: Fragile X Syndrome

Market Spotlight: Huntington’s Disease

Market Spotlight: Systemic Hypertension

Market Spotlight: Myelofibrosis (MF)

Market Spotlight: Cachexia

Parkinson’s disease forecast and market analysis to 2035

Disease Analysis: Epilepsy

Disease Analysis: Multiple Sclerosis

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

Alzheimer’s Disease Market and Forecast Analysis 2034

Pediatric Epilepsy KOL Interview – US, West

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)